162 related articles for article (PubMed ID: 16707437)
1. Mirk/Dyrk1b mediates cell survival in rhabdomyosarcomas.
Mercer SE; Ewton DZ; Shah S; Naqvi A; Friedman E
Cancer Res; 2006 May; 66(10):5143-50. PubMed ID: 16707437
[TBL] [Abstract][Full Text] [Related]
2. The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma.
Deng X; Ewton DZ; Li S; Naqvi A; Mercer SE; Landas S; Friedman E
Cancer Res; 2006 Apr; 66(8):4149-58. PubMed ID: 16618736
[TBL] [Abstract][Full Text] [Related]
3. Mirk/Dyrk1B: a multifunctional dual-specificity kinase involved in growth arrest, differentiation, and cell survival.
Mercer SE; Friedman E
Cell Biochem Biophys; 2006; 45(3):303-15. PubMed ID: 16845176
[TBL] [Abstract][Full Text] [Related]
4. The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer.
Jin K; Park S; Ewton DZ; Friedman E
Cancer Res; 2007 Aug; 67(15):7247-55. PubMed ID: 17671193
[TBL] [Abstract][Full Text] [Related]
5. Mirk protein kinase is a mitogen-activated protein kinase substrate that mediates survival of colon cancer cells.
Lee K; Deng X; Friedman E
Cancer Res; 2000 Jul; 60(13):3631-7. PubMed ID: 10910078
[TBL] [Abstract][Full Text] [Related]
6. Mirk/Dyrk1B mediates survival during the differentiation of C2C12 myoblasts.
Mercer SE; Ewton DZ; Deng X; Lim S; Mazur TR; Friedman E
J Biol Chem; 2005 Jul; 280(27):25788-801. PubMed ID: 15851482
[TBL] [Abstract][Full Text] [Related]
7. Construction of conditional lentivirus-mediated shRNA vector targeting the human Mirk gene and identification of RNAi efficiency in rhabdomyosarcoma RD cells.
Zhao B; Yang C; Yang S; Gao Y; Wang J
Int J Oncol; 2013 Oct; 43(4):1253-9. PubMed ID: 23913162
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.
van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT
Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
Marampon F; Ciccarelli C; Zani BM
Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation profiles of protein kinases in alveolar and embryonal rhabdomyosarcoma.
Cen L; Arnoczky KJ; Hsieh FC; Lin HJ; Qualman SJ; Yu S; Xiang H; Lin J
Mod Pathol; 2007 Sep; 20(9):936-46. PubMed ID: 17585318
[TBL] [Abstract][Full Text] [Related]
11. Mirk/dyrk1B is a Rho-induced kinase active in skeletal muscle differentiation.
Deng X; Ewton DZ; Pawlikowski B; Maimone M; Friedman E
J Biol Chem; 2003 Oct; 278(42):41347-54. PubMed ID: 12902328
[TBL] [Abstract][Full Text] [Related]
12. Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells.
Gao J; Zheng Z; Rawal B; Schell MJ; Bepler G; Haura EB
Cancer Biol Ther; 2009 Sep; 8(17):1671-9. PubMed ID: 19633423
[TBL] [Abstract][Full Text] [Related]
13. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt.
McDaneld TG; Spurlock DM
J Anim Sci; 2008 Nov; 86(11):2897-902. PubMed ID: 18641171
[TBL] [Abstract][Full Text] [Related]
14. Mirk/dyrk1B kinase destabilizes cyclin D1 by phosphorylation at threonine 288.
Zou Y; Ewton DZ; Deng X; Mercer SE; Friedman E
J Biol Chem; 2004 Jun; 279(26):27790-8. PubMed ID: 15075324
[TBL] [Abstract][Full Text] [Related]
15. SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.
Coda DM; Lingua MF; Morena D; Foglizzo V; Bersani F; Ala U; Ponzetto C; Taulli R
Cell Cycle; 2015; 14(9):1389-402. PubMed ID: 25644430
[TBL] [Abstract][Full Text] [Related]
16. MYCN expression in human rhabdomyosarcoma cell lines and tumour samples.
Toffolatti L; Frascella E; Ninfo V; Gambini C; Forni M; Carli M; Rosolen A
J Pathol; 2002 Apr; 196(4):450-8. PubMed ID: 11920742
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-induced apoptosis in rhabdomyosarcoma cell lines is dependent on pre-mitochondrial Bax activation and post-mitochondrial caspases.
Phillips DC; Martin S; Doyle BT; Houghton JA
Cancer Res; 2007 Jan; 67(2):756-64. PubMed ID: 17234787
[TBL] [Abstract][Full Text] [Related]
18. Mirk/Dyrk1B in cancer.
Friedman E
J Cell Biochem; 2007 Oct; 102(2):274-9. PubMed ID: 17583556
[TBL] [Abstract][Full Text] [Related]
19. Different expression profiles of Y-box-binding protein-1 and multidrug resistance-associated proteins between alveolar and embryonal rhabdomyosarcoma.
Oda Y; Kohashi K; Yamamoto H; Tamiya S; Kohno K; Kuwano M; Iwamoto Y; Tajiri T; Taguchi T; Tsuneyoshi M
Cancer Sci; 2008 Apr; 99(4):726-32. PubMed ID: 18377424
[TBL] [Abstract][Full Text] [Related]
20. [Study on microtubulin of human rhabdomyosarcoma].
Ye L; Zhang HY; Bu H; Yang GH; Zhang J; Guo LX; Wang SL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):50-3. PubMed ID: 14981814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
